Figure 3
DFS according to treatment arm, after censoring the observation in transplanted patients. Predicted 5-year DFS was 41% for the HiDAC group (n = 389; red line) and 36% for the multiagent CT group (n = 392; blue line; P = .608).
DFS according to treatment arm, after censoring the observation in transplanted patients. Predicted 5-year DFS was 41% for the HiDAC group (n = 389; red line) and 36% for the multiagent CT group (n = 392; blue line; P = .608).
